With T2DM progressing over time, by increasing insulin resistance and impaired beta-cell function, the need of antidiabetic drugs to maintain glycemic control increases, and eventually, the beta-cell function is impaired to an extent where exogenous insulin is needed. The gene discussed is INS; the disease is Insulin resistance.